Abstract
Transfusion-transmitted viral infections, including hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV) infections continue to be a major challenge in hemophilia patient. This study was conducted to assess the seroprevalence of HBV, HCV, and HIV infections among Iranian hemophilia patients. A cross-sectional study was conducted on 580 hemophilia patients (mean age ± SD = 27.11 ± 14.9) referred to the Namazi hospital, Shiraz University of medical sciences, Shiraz, Iran during July 2012 to August 2015. Blood samples were taken from the patients and tested for HBV surface antigen (HBsAg), antibody to HBV surface antigen (anti-HBs), antibody to HBV core antigen (anti-HBc), anti-HCV antibody (HCVAb), and anti-HIV antibody (HIVAb). The association of HBV, HCV, and HIV infections with age, sex, type of hemophilia (A or B), severity of hemophilia, blood group system, history of blood transfusion, and surgery were statistically analyzed using SPSS software and chi-square/Fisher exact tests. The seroprevalence of HCVAb and HBsAg were 11.4 % (66/580) and 0.2 % (1/580), respectively. None of the hemophilia patients were positive for HIV antibody. There was a significant association between HCV seropositivity and age (P < 0.001), severity of hemophilia (P < 0.0001), and history of blood transfusion (P = 0.050). It seems that strategies for prevention of HBV and HIV infections have been successful in south of Iran, but HCV is still a major infection of concern in multi-transfused patients.
Similar content being viewed by others
References
Al-Kubaisy W, Al-Naib K, Habib M (2006) Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad. East Mediterr Health J 12:264–269
Alavian S, Ardeshiri A, Hajarizadeh B (2003) Prevalence of HCV, HBV and HIV infections among hemophiliacs. Hakim Res J 2:45–51
Alavian SM, Fallahian F, Lankarani KB (2007) The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 16:403–406
Assarehzadegan MA, Boroujerdnia MG, Zandian K (2012) Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in Ahvaz, Southwest Iran. Iran Red Crescent Med J 14:470–474
Bahakim H, Bakir T, Arif M, Ramia S (1991) Hepatitis C virus antibodies in high-risk Saudi groups. Vox Sang 60:162–164
Barbosa AP, Martins R, Teles SA, Silva SA, Oliveira JM, Yoshida CF (2002) Prevalence of hepatitis C virus infection among hemophiliacs in Central Brazil. Mem Inst Oswaldo Cruz 97:643–644
Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH (1990) Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 76:254–256
de Paula EV, Gonçales NS, Xueref S, Addas-Carvalho M, Gilli SC, Angerami RN, et al. (2005) Transfusion-transmitted infections among multi-transfused patients in Brazil. J Clin Virol 34:S27–S32
Farshadpour F, Makvandi M, Samarbafzadeh A, Jalalifar M (2010) Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran. Indian J Med Microbiol 28:54–56
Fletcher M, Trowell J, Craske J, Pavier K, Rizza C (1983) Non-a non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J 287:1754–1757
Ghosh K, Joshi S, Shetty S, Pawar A (2000) Transfusion transmitted diseases in haemophilics from western India. Indian J Med Res 112:61–64
Kalantari H, Mirzabaghi A, Akbari M, Shahshahan Z (2011) Prevalence of hepatitis C virus, hepatitis B virus, human immunodeficiency virus and related risk factors among hemophilia and thalassemia patients in Iran. Arch Clin Infect Dis 6:82–84
Karimi M, Yarmohammadi H, Ardeshiri R, Yarmohammadi H (2002) Inherited coagulation disorders in southern Iran. Haemophilia 8:740–744
Mandell G, Bennett J, Dolin R (2011) Mandell, Douglas and Bennett's principles and practice of infectious diseases. Elsevier Churchhill Livingstone, Philadelphia
Mansour-Ghanaei F, Fallah MS, Shafaghi A, Yousefi-Mashhoor M, Ramezani N, Farzaneh F, Nassiri R (2002) Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Med Sci Monit 8:797–800
Merat S, Rezvan H, Nouraie M, Jamali J, Assari S, Abolghasemi H, et al. (2009) The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med 12:225–231
Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi M-J, et al. (2006) Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med 9:319–323
Preston F, Jarvis L, Makris M, Philp L, Underwood J, Ludlam C, Simmonds P (1995) Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease. Blood 85:1259–1262
Rafiei A, Darzyani AM, Taheri S, Haghshenas M, Hosseinian A, Makhlough A (2013) Genetic diversity of HCV among various high risk populations (IDAs, thalassemia, hemophilia, HD patients) in Iran. Asian Pac J Trop Med 6:556–560
Rezvan H, Abolghassemi H, Kafiabad SA (2007) Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med 17:425–433
Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M (2007) Hepatitis B and C virus infections in patients with hemophilia in Zahedan, Southeast Iran. Saudi Med J 28:1516–1519
Troisi CL, Hollinger FB, Hoots W, Contant C, Gill J, Ragni M, et al. (1993) A multicenter study of viral hepatitis in a United States hemophilic population. Blood 81:412–418
Waheed Y, Shafi T, Safi SZ, Qadri I (2009) Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol 15:5647
Wanachiwanawin W, Luengrojanakul P, Sirangkapracha P, Leowattana W, Fucharoen S (2003) Prevalence and clinical significance of hepatitis C virus infection in Thai patients with thalassemia. Int J Hematol 78:374–378
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Shiraz University of medical sciences committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Nezhad, S.M., Esmailnejad, A., Sanie, M.S. et al. Prevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infections among hemophilia patients in Shiraz, south of Iran. Comp Clin Pathol 25, 953–957 (2016). https://doi.org/10.1007/s00580-016-2286-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-016-2286-1